Related Experiment Video
Updated: Aug 19, 2026

Implementation of a Permeable Membrane Insert-based Infection System to Study the Effects of Secreted Bacterial Toxins on Mammalian Host Cells
Published on: August 19, 2016
Mechanisms of blister formation by staphylococcal toxins
Yasushi Hanakawa1, John R Stanley
1Department of Dermatology, School of Medicine, Ehime University, Shitukawa, Toon, Ehime 791-0295, Japan. hanakawa@m.ehime-u.ac.jp
Insights
Staphylococcus aureus exfoliative toxins (ETs) cause skin diseases by cleaving desmoglein 1 (Dsg1), a molecule crucial for skin barrier integrity. This mechanism is also implicated in autoimmune conditions like pemphigus foliaceus.
Area of Science:
- Microbiology
- Dermatology
- Biochemistry
Background:
- Bacterial skin infections like bullous impetigo and staphylococcal scalded skin syndrome (SSSS) affect many children.
- These diseases are caused by Staphylococcus aureus producing exfoliative toxins (ETs).
- ETs cleave desmoglein 1 (Dsg1), a key protein for epidermal structure and barrier function.
Purpose of the Study:
- To elucidate the mechanism by which Staphylococcus aureus exfoliative toxins (ETs) cause skin diseases.
- To understand the interaction between ETs and desmoglein 1 (Dsg1).
Main Methods:
- Analysis of the crystal structure of ETs.
- Investigation of the binding and cleavage activity of ETs on Dsg1.
- Comparison of skin pathologies in bacterial infections and autoimmune diseases.
Main Results:
- ETs function as serine proteases, with their catalytic site activated upon binding to a receptor.
- Dsg1 specifically binds and activates ETs, leading to cleavage at a single peptide bond.
- This cleavage is dependent on the calcium-dependent conformation of Dsg1.
- Identical skin pathologies are observed in SSSS/bullous impetigo and pemphigus foliaceus, where Dsg1 is the antibody target.
Conclusions:
- Staphylococcus aureus utilizes ETs to disrupt the human epidermal barrier for survival and proliferation.
- ETs exhibit high specificity for human Dsg1.
- The findings provide insight into the pathogenesis of S. aureus skin infections and autoimmune blistering diseases.
Abstract:
Many children suffer from the bacterial skin diseases bullous impetigo and staphylococcal scalded skin syndrome (SSSS). Staphylococcus aureus, which produces exfoliative toxins (ETs), causes these diseases. Recently, it was proven that ETs cleave the cell adhesion molecule desmoglein (Dsg) 1, which plays an important role in maintaining the proper structure and barrier function of the epidermis. Surprisingly, Dsg1 is also the antibody target in the autoimmune disease pemphigus foliaceus. Skin biopsies from pemphigus foliaceus patients show the same pathology as those from bullous impetigo and SSSS patients. The crystal structure of ET suggests that it is a serine protease with an inactive catalytic site, which may become activated when ET binds a specific receptor. This receptor binding is thought to cause a change in conformation that exposes the catalytic site. It has recently been shown that Dsg1 specifically binds and activates ET, which in turn cleaves the bound Dsg1 at only one peptide bond. This process is absolutely dependent on the calcium-dependent conformation of Dsg1. These data suggest that ETs have a very high specificity for human Dsg1, and that S. aureus uses ETs to disrupt the barrier of the human epidermis in order to survive and proliferate on the human body.
Related Concept Videos
Bacterial Toxins
Staphylococcal Skin Infections
Determinants of Bacterial Pathogenicity and Virulence
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Mechanism of Antibiotic Resistance in MRSA
Inhalation Anthrax

